Navigation Links
Delcath Appoints Gregory Gores, M.D. to Medical Advisory Board
Date:12/21/2011

initial launch and distribution of the CHEMOSAT system Europe, CE Marking for the Generation Two system and the timing of our commercial launch in Europe, the time required to build inventory and establish commercial operations in Europe, adoption, use and resulting sales, if any, for the Hepatic CHEMOSAT delivery system in the EEA, our ability to successfully commercialize the chemosaturation system and the potential of the chemosaturation system as a treatment for patients with terminal metastatic disease in the liver, acceptability of the Phase III clinical trial data by the FDA, our ability to address the issues raised in the Refusal to File letter received from the FDA and the timing of our re-submission of our NDA, re-submission and acceptance of the Company's NDA by the FDA, approval of the Company's NDA for the treatment of metastatic melanoma to the liver, adoption, use and resulting sales, if any, in the United States, approval of the current or future chemosaturation system for other indications, actions by the FDA or other foreign regulatory agencies, our ability to obtain reimbursement for the CHEMOSAT system, our ability to successfully enter into distribution and strategic partnership agreements in foreign markets and the corresponding revenue associated with such foreign markets, uncertainties relating to the results of research and development projects and future clinical trials, and uncertainties regarding our ability to obtain financial and other resources for any research, development and commercialization activities. These factors, and others, are discussed from time to time in our filings with the Securities and Exchange Commission. You should not place undue reliance on these forward-looking statements, which speak only as of the date they are made. We undertake no obligation to publicly update or revise these forward-looking statements to reflect events or circumstances after the date they are made.Contact Information:Investor Contact: <
'/>"/>
SOURCE Delcath Systems, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Delcath Expands Phase III Trial for Metastatic Melanoma to Include University of Maryland Medical Center
2. Delcath Updates Phase III Patient Enrollment as Pivotal Trial Accelerates, Durable Tumor Responses In Phase II Study Also Cited
3. Delcath Expands Phase III Trial for Metastatic Melanoma to Include St. Lukes Cancer Center
4. Delcath Adds Dr. Pamela R. Contag to Its Board of Directors
5. Delcath Continues Expansion of Clinical Trial Centers Offering PHP(TM)
6. Enrollment in Delcaths Pivotal Phase III Metastatic Melanoma Clinical Trial Achieves Seventy-Five Percent Accrual
7. Data Safety Monitoring Board Unanimously Recommends Continuation of Delcaths Phase III Clinical Trial
8. Delcath Systems, Inc. Appoints Dr. Krishna Kandarpa its Executive Vice President R&D and Chief Medical Officer
9. Delcath Systems, Inc. Completes Phase III Study Enrollment
10. Delcath Systems Begins Data Analysis of Phase III Trial
11. Delcath Systems, Inc. to Present at the 12th Annual Needham Growth Stock Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)...  Roche (SIX: RO, ROG; OTCQX: RHHBY) launched its ... 2014 Clinical Lab Expo today by unveiling two booths ... is partnering with customers to redefine the value of ... day that they,re looking for a partner to help ... and offices," said Jack Phillips , president and ...
(Date:7/29/2014)... DUBLIN , July 29, 2014 ... the "Global Respiratory Devices Market 2014-2018" report ... A respiratory device is a medical ... who is having difficulty in breathing and cannot achieve ... disorders such as cystic fibrosis, asthma, COPD, and ARDS ...
(Date:7/29/2014)... Medical Corporation (Apex, TWSE: 4106), a leading player in the ... is appealing the judgment of the Regional Court of ... that found the headgear of certain mask models infringe a ... against various ResMed patents in major countries. Apex further reiterates ... ResMed filed the lawsuit with the Regional ...
Breaking Medicine Technology:Roche focuses on partnering with customers to redefine the value of the laboratory at the AACC 2014 Clinical Lab Expo 2Roche focuses on partnering with customers to redefine the value of the laboratory at the AACC 2014 Clinical Lab Expo 3Roche focuses on partnering with customers to redefine the value of the laboratory at the AACC 2014 Clinical Lab Expo 4Global Respiratory Devices Market 2014-2018 2Apex Continues Fighting Against Patents to Free Up Competition 2
... -- China Medical Technologies, Inc. (the "Company") (Nasdaq: ... ("IVD") company, today announced that its subsidiary, Beijing GP ... sixth in the Deloitte Technology Fast 50 China 2010 ... molecular diagnostic businesses of the Company. The ...
... Oct. 21 Investigators from Texas Children,s Hospital ... North America came together in Houston to analyze ... the Berlin Heart EXCOR® Pediatric Ventricular Assist Device ... more about the study, see: http://bit.ly/bfrA1J ...
Cached Medicine Technology:China Medical Technologies Announces its Subsidiary, GP Medical, Ranked Sixth in Deloitte Technology Fast 50 China 2010 Program 2Texas Children's Hospital Hosts North American Investigators on Berlin Heart Trial 2Texas Children's Hospital Hosts North American Investigators on Berlin Heart Trial 3Texas Children's Hospital Hosts North American Investigators on Berlin Heart Trial 4
(Date:7/29/2014)... Historically, Memorial Day kicks off a ... celebrated throughout that time by picnics, barbecues and beach ... mark the start of a period that will witness ... In 2012 nearly 1.000 people were killed in crashes ... to Labor Day. , The summer's warmer weather, longer ...
(Date:7/29/2014)... 29, 2014 During his 37 years in ... & Associates, has had a steady stream of college students ... students have now gone on to dental school and some ... the shadowing program helps college students find success. , For ... given them the chance to see a realistic view of ...
(Date:7/29/2014)... 2014 A team of scientists, led ... PhD, has developed a blood test for Alzheimer’s disease ... development of Alzheimer’s disease interventions, according to an article ... puzzle, and this study represents one of several pieces ... past couple of years,” Ethell said. , The study, ...
(Date:7/29/2014)... 2014 Just months after the recent ... new states, the exciting FX family does it again! ... time farmboy from Arkansas, is shocking the world with ... technologies to the masses. This time with their ... of Jamaica. This new office is scheduled to ...
(Date:7/29/2014)... News) -- Successful negotiations may depend on more than diplomacy. ... have an advantage, according to a new study. ... successful when negotiating for themselves than men with narrower faces. ... asset when negotiations require collaboration and compromise, the researchers found. ... or not. It,s not just the big things, like a ...
Breaking Medicine News(10 mins):Health News:Narconon New Life Retreat Launches New Alcohol Prevention Program 2Health News:Arthur Bruce Dental Helps College Students 2Health News:Professor Develops Blood Test for Alzheimer’s Disease Risk 2Health News:Atlanta Special FX Rapidly Expanding Just Opens First International Corporate Office in Jamaica 2Health News:Wider Face May Give You an Edge in Negotiations 2
... CITY, Oct. 5 /PRNewswire-FirstCall/ - DiagnoCure Inc. (TSX: CUR), ... and delivering laboratory services, announced that it signed an ... provider of diagnostic products and services, for the promotion, ... Staging Test in the United Kingdom and Ireland. Lab21 ...
... CUR , QUEBEC CITY, Oct. 5 /PRNewswire-FirstCall/ - DiagnoCure ... cancer diagnostic tests and delivering laboratory services, announced that ... Lab21, a global provider of diagnostic products and services, ... GCC Colorectal Cancer Staging Test in the United Kingdom ...
... ... Life Insurance by KF Financial, Inc. has just launched its new, ... break from typical insurance websites with its comprehensive information, up to ... for Life Insurance is nationally recognized for helping physicians, dentists and ...
... The Lupus Foundation of America ... WASHINGTON, Oct. 5 Today, The Lewin Group, a national ... the barriers that have obstructed lupus drug development resulting in ... 50 years - since the Eisenhower Administration. The ...
... Full Extent of the Prematurity Crisis Still Unknown, March of Dimes ... than one million infants die each year because they are born ... Global and Regional Toll of Preterm Birth. , The new ... worldwide were born preterm -- defined as birth at less than ...
... combination of medications and a particular light therapy is effective ... subtropical climates. In a paper presented at the 2009 ... (AAO-HNSF) Annual Meeting & OTO EXPO in San Diego, researchers ... on dysplasia and carcinomas of the head and neck. It ...
Cached Medicine News:Health News:/R E P E A T -- DiagnoCure signs distribution agreement in the UK for its colorectal cancer test/ 2Health News:/R E P E A T -- DiagnoCure signs distribution agreement in the UK for its colorectal cancer test/ 3Health News:DiagnoCure signs distribution agreement in the UK for its colorectal cancer test 2Health News:DiagnoCure signs distribution agreement in the UK for its colorectal cancer test 3Health News:New Website for Disability Insurance Launched by Set for Life Insurance by KF Financial 2Health News:National Report Shines Light on Lupus 50-Year Treatment Drought 2Health News:National Report Shines Light on Lupus 50-Year Treatment Drought 3Health News:Global Death Toll: One Million Premature Babies Every Year 2Health News:Global Death Toll: One Million Premature Babies Every Year 3Health News:Global Death Toll: One Million Premature Babies Every Year 4Health News:Global Death Toll: One Million Premature Babies Every Year 5
0.5mm 1X2 Teeth with 6mm Tying Platform; in Stainless Steel 125...
... necessary addition to any ... Reichert Trial Frame provides ... smooth controls for quick, ... design, high-quality materials, and ...
... CTS utilizes a small-cone design and ... a complete, shadow-free representation of the ... system that includes the topographer, PC, ... software enables quick and easy access ...
... AL500 incorporates all of the features you ... well as a color display, auto add-lock, ... design fits easily into your existing workspace, ... glare-free viewing at any angle.,Quick and accurate, ...
Medicine Products: